Successful treatment of septic shock due to pan-resistant Acinetobacter baumannii using combined antimicrobial therapy including tigecycline

被引：86

作者：

Taccone, F. S.

Rodriguez-Villalobos, H.

De Backer, D.

De Moor, V.

Deviere, J.

Vincent, J. -L.

Jacobs, F.

机构：

[1] Univ Brussels, Erasme Univ Hosp, Dept Infect Dis, B-1070 Brussels, Belgium

[2] Univ Brussels, Erasme Univ Hosp, Dept Microbiol, B-1070 Brussels, Belgium

[3] Univ Brussels, Erasme Univ Hosp, Dept Digest Surg, B-1070 Brussels, Belgium

[4] Univ Brussels, Erasme Univ Hosp, Dept Intens Care, B-1070 Brussels, Belgium

[5] Univ Brussels, Erasme Univ Hosp, Dept Gastroenterol, B-1070 Brussels, Belgium

来源：

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES | 2006年 / 25卷 / 04期

关键词：

tigecycline; septic shock; Acinetobacter baumannii; pan-drug-resistant;

D O I：

10.1007/s10096-006-0123-1

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Reported here is the case of a patient with septic shock due to multidrug-resistant Acinetobacter baumannii, which developed after complicated acute pancreatitis with intra-abdominal abscess. Treatment with colistin methanesulphonate and high doses of meropenem were initiated, but since shock persisted, tigecycline was added to the regimen, resulting in successful resolution of the infection.

引用

页码：257 / 260

页数：4

共 13 条

[1] In vitro activities of tigecycline (GAR-936) against recently isolated clinical bacteria in Spain
Betriu, C
Rodríguez-Avial, I
Sánchez, BA
Gómez, M
Alvarez, J
Picazo, JJ
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (03) : 892 - 895
[2] Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY:: molecular epidemiology and in vitro activity of polymyxin B and other agents
Bratu, S
Tolaney, P
Karumudi, U
Quale, J
Mooty, M
Nichani, S
Landman, D
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 56 (01) : 128 - 132
[3] DARTOIS N, 2004, 44 ANN INT C ANT AG
[4] Colistin: The revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections
Falagas, ME
Kasiakou, SK
[J]. CLINICAL INFECTIOUS DISEASES, 2005, 40 (09) : 1333 - 1341
[5] Tigecycline: an investigational glycylcycline antimicrobial with activity against resistant gram-positive organisms
Garrison, MW
Neumiller, JJ
Setter, SM
[J]. CLINICAL THERAPEUTICS, 2005, 27 (01) : 12 - 22
[6] Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936)
Henwood, CJ
Gatward, T
Warner, M
James, D
Stockdale, MW
Spence, RP
Towner, KJ
Livermore, DM
Woodford, N
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 (03) : 479 - 487
[7] Dissemination of a clone of unusual phenotype of pandrug-resistant Acinetobacter baumannii at a University Hospital in Taiwan
Kuo, LC
Teng, LJ
Yu, CJ
Ho, SW
Hsueh, PR
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (04) : 1759 - 1763
[8] The need for new antibiotics
Livermore, DM
[J]. CLINICAL MICROBIOLOGY AND INFECTION, 2004, 10 : 1 - 9
[9] MURRAY J, 2003, 43 ANN INT C ANT AG
[10] Activity of tigecycline (GAR-936) against Acinetobacter baumannii strains, including those resistant to imipenem
Pachón-Ibáñez, ME
Jiménez-Mejías, ME
Pichardo, C
Llanos, AC
Pachón, J
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (11) : 4479 - 4481

← 1 2 →